n (%) or mean (standard deviation) | |
---|---|
Posterior sectionectomy | 2 (15) |
Right/left hepatectomy | 10 (77) |
Right trisectionectomy | 1 (8) |
Operative time (min) | 323 (122.9) |
Estimated blood loss (mL) | 1439 (1372.7) |
Length of stay (days) | 14 (5.7) |
Wound infection | 2 |
Pleural effusion | 5 |
Intraabdominal collection | 1 |
Bile leakage | 1 |
Resection margins | |
R0 (free margins) | 10 (77) |
R1 (microscopically positive) | 3 (23) |
Tumor differentiation | |
Moderate | 5 (39) |
Poor | 8 (62) |
Satellite nodule positive | 3 (23) |
Characteristic | n (%) or mean (standard deviation) |
---|---|
Age (years) | 51.4 (9.5) |
Male sex | 12 (92) |
Hepatitis B virus (HBV) | 7 (54) |
HBV and hepatitis C virus (HCV) HBV | 2 (15) |
and hepatitis C infection (HCV) | 4 (31) |
Non-HBV/HCV | |
Tumor diameter (cm) | 11.2 (5.9) |
Child–Pugh A | 13 (100) |
α-Fetoprotein at diagnosis (IU/mL) | 13615 (41129) |
2nd branch portal vein (PV) | 3 (23) |
1st branch PV (right or left PV) | 4 (31) |
Main PV | 3 (23) |
Hepatic vein/inferior vena cava | 3 (23) |
Recurrence free survival | Overall survival | Prognostic factor |
---|---|---|
0.81 (0.20 to 3.25), 0.76 | 0.70 (0.09 to 5.09), 0.72 | Tumor size ≥10 cm |
2.07 (0.41 to 10.45), 0.37 | 3.54 (0.50 to 25.28), 0.21 | R0, tumor free resection margin |
2.80 (0.56 to 14.02), 0.18 | Liver cirrhosis | |
3.62 (0.44 to 30.04), 0.20 | Preop transarterial chemoembolization |